April 5, 2021

KRAS mutation shows worse tumor response after hepatic arterial infusion pump therapy for unresectable colorectal liver metastases

KRAS mutation is predictive of worse results after metastasectomy or adjuvant chemotherapy with hepatic arterial infusion (HAI) pump in the treatment of liver metastases in colorectal cancer patients. However, the KRAS mutation effect on tumor […]
March 31, 2021

CheckMate 577 is the first trial to demonstrate the effectiveness of immunotherapy in the adjuvant setting for esophageal cancer or TEG

Although trimodal therapy (neoadjuvant chemoradiation therapy followed by surgery) is the current standard, the risk of relapse is high, especially for 70% to 75% of patients who do not […]